Cornelio G. Caday
About
In The Last Decade
Cornelio G. Caday
16 papers receiving 967 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 580
- Cellular and Molecular Neuroscience 357
- Developmental Neuroscience 215
- Neurology 125
- Cell Biology 121
Countries citing papers authored by Cornelio G. Caday
This map shows the geographic impact of Cornelio G. Caday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelio G. Caday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelio G. Caday more than expected).
Fields of papers citing papers by Cornelio G. Caday
This network shows the impact of papers produced by Cornelio G. Caday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelio G. Caday. The network helps show where Cornelio G. Caday may publish in the future.
Co-authorship network of co-authors of Cornelio G. Caday
This figure shows the co-authorship network connecting the top 25 collaborators of Cornelio G. Caday. A scholar is included among the top collaborators of Cornelio G. Caday based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelio G. Caday. Cornelio G. Caday is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Preferential inhibition of glioblastoma cells with wild-type epidermal growth factor receptors by a novel tyrosine kinase inhibitor ethyl-2,5-dihydroxycinnamate. | 12 |
| 2 | 70 | |
| 3 | Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. | 95 |
| 4 | 120 | |
| 5 | 64 | |
| 6 | 7 | |
| 7 | 81 | |
| 8 | Growth factor expression after stroke. | 56 |
| 9 | 21 | |
| 10 | 12 | |
| 11 | 5 | |
| 12 | 334 | |
| 13 | 20 | |
| 14 | 22 | |
| 15 | 32 | |
| 16 | 33 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.